KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
  is the largest association representing the Korean pharmaceutical and biotech industry.

Established in 1945 under the authorization of the Ministry of Health and Welfare(MoHW), the association is dedicated to advancing national healthcare through the sustainable development of the pharmaceutical sector.

KPBMA plays key roles in industry advancement, such as invigorating R&D through open innovation,
supporting policy improvement, expanding business into global markets, and contributing to healthcare promotion in international society.

Our membership includes not only Korean pharmaceutical companies but also biotech firms specializing in digital therapeutics and artificial intelligence,
as well as multinational pharmaceutical companies.
Together with our member companies, we form 24 committees to discuss and make decisions on issues related to the pharmaceutical industry.